Cutaneous adverse reactions in a lung cancer patient treated with pembrolizumab: A case report
Author(s) -
Carmen Bobeică,
Laura Rebegea,
Gabriel Murariu,
Michaela Dobre,
Aurel Nechita,
Alin Laurenţiu Tatu,
Eleiculeț,
Lucreția Anghel,
Silvia Fotea,
Mihaela Crăescu
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10937
Subject(s) - medicine , lung cancer , pembrolizumab , oncology , adverse effect , cancer , adenocarcinoma , epidermal growth factor receptor , treatment of lung cancer , radiation therapy , immunotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom